Page last updated: 2024-08-24

fluorodeoxyglucose f18 and Thrombocythemia

fluorodeoxyglucose f18 has been researched along with Thrombocythemia in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's2 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Bénard, F; Boileau, R; Boucher, L; Larivée, P; Prévost, S1
Au, WY; Kwong, YL; Leung, G; Liang, R; Ma, SK; Ooi, GC; Shek, TW1

Other Studies

2 other study(ies) available for fluorodeoxyglucose f18 and Thrombocythemia

ArticleYear
Bone marrow hypermetabolism on 18F-FDG PET as a survival prognostic factor in non-small cell lung cancer.
    Journal of nuclear medicine : official publication, Society of Nuclear Medicine, 2006, Volume: 47, Issue:4

    Topics: Adult; Aged; Aged, 80 and over; Analysis of Variance; Bone Marrow; Carcinoma, Non-Small-Cell Lung; Female; Fluorodeoxyglucose F18; Humans; Hypercalcemia; L-Lactate Dehydrogenase; Lung Neoplasms; Male; Middle Aged; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Retrospective Studies; Thrombocytopenia; Thrombocytosis

2006
Myeloblastoma (chloroma) in leukemia: case 2. Meningeal granulocytic sarcoma (chloroma) in essential thrombocythemia.
    Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2000, Dec-01, Volume: 18, Issue:23

    Topics: Antineoplastic Agents, Alkylating; Female; Fluorodeoxyglucose F18; Humans; Leukemia, Myeloid; Melphalan; Meningeal Neoplasms; Middle Aged; Neoplasms, Second Primary; Thrombocytosis; Tomography, Emission-Computed

2000